Alessandra Gambineri - S. Orsola-Malpighi Hospital, University of Bologna

Laura Rotolo,Alessandra Gambineri, Valentina Bissi, Francesca Zauli, Greta Galante,Carolina Cecchetti, Paola Dionese, Elisabetta Belardinelli, Beatrice Solmi, Uberto Pagotto,Flaminia Fanelli

Endocrine Abstracts (2024)

Cited0Views0Bibtex

Evolution of cardiovascular risk markers in polycystic ovary syndrome: Results from a long-term monocentric cohort study

Carolina Cecchetti,Srdjan Pandurevic, Paola Dionese,Elisabetta Belardinelli, Laura Rotolo,Flaminia Fanelli,Luca Bergamaschi,Carmine Pizzi, Uberto Pagotto,Alessandra Gambineri

Endocrine Abstracts (2023)

Cited0Views0Bibtex

Assessment of Type 2 Diabetes Risk in Young Women with Polycystic Ovary Syndrome

Sarantis Livadas,Rodis Paparodis,Panagiotis Anagnostis,Alessandra Gambineri,Jelica Bjekić-Macut, Tijana Petrović,Bulent O Yildiz,Dragan Micić,George Mastorakos,Djuro Macut

Diagnostics (Basel, Switzerland)no. 12 (2023): 2067-2067

Cited4Views0WOSBibtex

THU649 PCOS Phenotype In Unselected Populations (P-PUP) Study: Defining And Comparing Hirsutism Across Various Ethnic Groups In Unselected Populations

Sylvia Kiconco,Anju E. Joham, Л. В. Сутурина,Xiaomiao Zhao,Alessandra Gambineri,Fahimeh Ramezani Tehrani,Bülent O. Yildiz,Jinju Kim,Helena Teede, Ricardo Azziz

Journal of the Endocrine Societyno. Supplement_1 (2023)

Cited0Views0Bibtex

SAT380 Clinical, Metabolic And Hormonal Profile In Women Carrying Cyp21a2 Mutations

Sarantis Livadas,Dimitrios G. Goulis, Elisabetta Belardinelli,Eleni Armeni, Beatrice Solmi,Stavroula Veneti,Ιrene Lambrinoudaki,Carolina Cecchetti,Djuro Macut,Alessandra Gambineri

Journal of the Endocrine Societyno. Supplement_1 (2023)

Cited0Views0Bibtex

Is it possible to achieve an acceptable disease control by dietary therapy alone in Berardinelli Seip type 1? Experience from a case report

Carolina Cecchetti,Elisabetta Belardinelli, Paola Dionese,Rita Teglia,Roberta Fazzeri,M. Rosaria D' Apice,Amanda Vestito, Uberto Pagotto,Alessandra Gambineri

Frontiers in endocrinology (2023): 1190363-1190363

Cited0Views0WOSBibtex

SPIOMET4HEALTH—efficacy, tolerability and safety of lifestyle intervention plus a fixed dose combination of spironolactone, pioglitazone and metformin (SPIOMET) for adolescent girls and young women with polycystic ovary syndrome: study protocol for a multicentre, randomised, double-blind, placebo-controlled, four-arm, parallel-g..

Cristina Garcia-Beltran,Rita Malpique,Marianne S. Andersen,Firdevs Bas,Judit Bassols,Feyza Darendeliler,Marta Díaz, Barbara Dieris,Flaminia Fanelli,Elke Fröhlich-Reiterer,Alessandra Gambineri,Dorte Glintborg,

Trials（2023）

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn